PLoS ONE (Jan 2015)

Treatment of irradiated mice with high-dose ascorbic acid reduced lethality.

  • Tomohito Sato,
  • Manabu Kinoshita,
  • Tetsuo Yamamoto,
  • Masataka Ito,
  • Takafumi Nishida,
  • Masaru Takeuchi,
  • Daizoh Saitoh,
  • Shuhji Seki,
  • Yasuo Mukai

DOI
https://doi.org/10.1371/journal.pone.0117020
Journal volume & issue
Vol. 10, no. 2
p. e0117020

Abstract

Read online

Ascorbic acid is an effective antioxidant and free radical scavenger. Therefore, it is expected that ascorbic acid should act as a radioprotectant. We investigated the effects of post-radiation treatment with ascorbic acid on mouse survival. Mice received whole body irradiation (WBI) followed by intraperitoneal administration of ascorbic acid. Administration of 3 g/kg of ascorbic acid immediately after exposure significantly increased mouse survival after WBI at 7 to 8 Gy. However, administration of less than 3 g/kg of ascorbic acid was ineffective, and 4 or more g/kg was harmful to the mice. Post-exposure treatment with 3 g/kg of ascorbic acid reduced radiation-induced apoptosis in bone marrow cells and restored hematopoietic function. Treatment with ascorbic acid (3 g/kg) up to 24 h (1, 6, 12, or 24 h) after WBI at 7.5 Gy effectively improved mouse survival; however, treatments beyond 36 h were ineffective. Two treatments with ascorbic acid (1.5 g/kg × 2, immediately and 24 h after radiation, 3 g/kg in total) also improved mouse survival after WBI at 7.5 Gy, accompanied with suppression of radiation-induced free radical metabolites. In conclusion, administration of high-dose ascorbic acid might reduce radiation lethality in mice even after exposure.